NYLIM
ZYME icon

New York Life Investment Management’s Zymeworks ZYME Stock Holding History

New York Life Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,058
Closed -$358K – 1347
2024
Q1 		$358K Buy
+34,058
New +$378K ﹤0.01% 1240

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

New York Life Investment Management's ZYME Position: Q2 2024 in Review

New York Life Investment Management sold out of Zymeworks (ZYME) in Q2 2024, closing a stake of 34,058 shares — an estimated $358K sold.

New York Life Investment Management first reported a position in ZYME in Q1 2024 and held it in 1 quarter. The position peaked at $358K in Q1 2024. 164 funds tracked by Wall St. Rank hold ZYME as of Q2 2024.

  • New York Life Investment Management reported no remaining Zymeworks position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 34,058 Zymeworks shares in Q2 2024, an estimated $358K.
  • New York Life Investment Management first reported a position in Zymeworks in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's Zymeworks position peaked at $358K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Zymeworks as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.